Therapeutic Approach

Archive: February, 2016

Ritter Pharmaceuticals Issued Two New Patents

LOS ANGELES (February 16, 2016) – Ritter Pharmaceuticals, Inc. (NASDAQ: RTTR) (“Ritter Pharmaceuticals” or the “Company”), a pharmaceutical company developing novel therapeutic products that modulate the human gut microbiome to treat gastrointestinal diseases, today announced that it recently has been issued U.S. Patent Nos. 9,200,303 and 9,226,933 by the U.S. Patent & Trademark Office. U.S. […]

Leave Your Comments »

Featuring Recent Posts WordPress Widget development by YD